We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
-14.06%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$179M
AUM Growth
-$17.4M
Cap. Flow
+$21.8M
Cap. Flow %
12.18%
Top 10 Hldgs %
59.55%
Holding
44
New
5
Increased
14
Reduced
14
Closed
10

Top Buys

1
QURE icon
uniQure
QURE
+$12.1M
2
UTHR icon
United Therapeutics
UTHR
+$10M
3
MGTX icon
MeiraGTx Holdings
MGTX
+$7.87M
4
RCM
R1 RCM Inc. Common Stock
RCM
+$4.82M
5
GH icon
Guardant Health
GH
+$3.67M

Top Sells

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$5.29M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.96M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.87M
4
QTTB icon
Q32 Bio
QTTB
+$4.07M
5
INDP icon
Indaptus Therapeutics
INDP
+$3.54M

Sector Composition

1 Healthcare 97.96%
2 Industrials 2.04%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLGT
26
DELISTED
Teligent, Inc
TLGT
$2.32M 1.3%
244,604
-52,168
-18% -$411K
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$2.31M 1.29%
587,626
+137,626
+31% +$1.11M
PSNL icon
28
Personalis
PSNL
$1.65B
$1.69M 0.94%
115,214
+58,768
+104% +$1.11M
CI icon
29
Cigna
CI
$78.8B
$1.67M 0.93%
11,000
-20,227
-65% -$3.29M
MTEM
30
DELISTED
Molecular Templates, Inc.
MTEM
$1.47M 0.82%
14,866
+1,687
+13% +$157K
RETA
31
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$988K 0.55%
+12,300
New +$1.04M
UROV
32
DELISTED
Urovant Sciences Ltd.
UROV
$972K 0.54%
102,657
-39,963
-28% -$347K
SRRA
33
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$924K 0.52%
59,168
-7,872
-12% -$151K
TPST icon
34
Tempest Therapeutics
TPST
$17.1M
$370K 0.21%
267
-112
-30% -$181K
EFOR
35
Everforth Inc
EFOR
$708M
– –
-30,000
Closed -$1.82M
ASMB icon
36
Assembly Biosciences
ASMB
$530M
– –
-16,667
Closed -$2.7M
CDTX
37
DELISTED
Cidara Therapeutics
CDTX
– –
-17,948
Closed -$603K
EOLS icon
38
Evolus
EOLS
$392M
– –
-112,590
Closed -$1.65M
EXAS
39
PUT
DELISTED
Exact Sciences
EXAS
– –
-14,100
Closed -$1.66M
INDP icon
40
Indaptus Therapeutics
INDP
$376M
– –
-364
Closed -$3.54M
KZR
41
DELISTED
Kezar Life Sciences
KZR
– –
-3,422
Closed -$264K
MODV
42
DELISTED
ModivCare
MODV
– –
-14,677
Closed -$842K
NGNE icon
43
Neurogene
NGNE
$787M
– –
-182
Closed -$9K
NVRO
44
DELISTED
NEVRO CORP.
NVRO
– –
-11,000
Closed -$713K
WCG
45
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-6,500
Closed -$1.85M
1
2

Similar funds

PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return
BFC
Blue Fin Capital Warren, Rhode Island $610M AUM 26.46% 1-Year Est. Return
ACM
Armbruster Capital Management Pittsford, New York $610M AUM 17.51% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $610M AUM 25.92% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return
CBB
Citizens Business Bank Ontario, California $610M AUM 27.86% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
IA
IFG Advisors St. Louis, Missouri $611M AUM 17.57% 1-Year Est. Return